Your browser doesn't support javascript.
loading
Extended interval dosing of natalizumab in multiple sclerosis.
Zhovtis Ryerson, L; Frohman, T C; Foley, J; Kister, I; Weinstock-Guttman, B; Tornatore, C; Pandey, K; Donnelly, S; Pawate, S; Bomprezzi, R; Smith, D; Kolb, C; Qureshi, S; Okuda, D; Kalina, J; Rimler, Z; Green, R; Monson, N; Hoyt, T; Bradshaw, M; Fallon, J; Chamot, E; Bucello, M; Beh, S; Cutter, G; Major, E; Herbert, J; Frohman, E M.
Affiliation
  • Zhovtis Ryerson L; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Frohman TC; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Foley J; Rocky Mountain MS Clinic, Salt Lake City, Utah, USA.
  • Kister I; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Weinstock-Guttman B; University of Buffalo, Buffalo, New York, USA.
  • Tornatore C; Georgetown University, Washington DC, USA.
  • Pandey K; Barnabas Health MS Center, Livingston, New Jersey, USA.
  • Donnelly S; CUNY Graduate Center, New York, New York, USA.
  • Pawate S; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Bomprezzi R; University of Massachusetts School of Medicine, Worcester, Massachusetts, USA.
  • Smith D; Multiple Sclerosis Center of Connecticut, Norwich, Connecticut, USA.
  • Kolb C; University of Buffalo, Buffalo, New York, USA.
  • Qureshi S; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Okuda D; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Kalina J; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Rimler Z; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Green R; Barnabas Health MS Center, Livingston, New Jersey, USA.
  • Monson N; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Hoyt T; Rocky Mountain MS Clinic, Salt Lake City, Utah, USA.
  • Bradshaw M; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Fallon J; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Chamot E; University of Alabama School of Public Health, Birmingham, Alabama, USA.
  • Bucello M; University of Buffalo, Buffalo, New York, USA.
  • Beh S; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Cutter G; University of Alabama School of Public Health, Birmingham, Alabama, USA.
  • Major E; National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
  • Herbert J; Department of Neurology, Langone Medical Center, New York University, New York, New York, USA.
  • Frohman EM; Departments of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Bioengineering, University of Texas at Dallas, Dallas, Texas, USA Depar
J Neurol Neurosurg Psychiatry ; 87(8): 885-9, 2016 Aug.
Article in En | MEDLINE | ID: mdl-26917698
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / Natalizumab / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2016 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / Natalizumab / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2016 Type: Article Affiliation country: United States